Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

Want to learn more about myeloma treatment in the UK?

Join experts Graham Jackson (@profghjackson) & Martin Kaiser in this exclusive session as they discuss:

- Muk Nine b: OPTIMUM
- Myeloma XI
- Genomics in myeloma

& more!

👉http://ow.ly/qqgH50JEOpX👈

#MMsm #HemOnc

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

On June 24, the @US_FDA approved lisocabtagene maraleucel (liso-cel) for second-line treatment of adult patients with LBCL. The efficacy of liso-cel has been evaluated in the TRANSFORM study.

Find out more here:

👉http://ow.ly/QqNu50JJj3z👈

#LymSM #HemOnc #CARTcell #ImmunoOnc

Dr. Caspian Oliai, who recently presented positive results on Orca-T at #EHA2022, spoke with @VJHemOnc about the potential for our lead investigational high-precision cell therapy to transform treatment for #bloodcancer patients. Watch his interview here: https://bit.ly/3njs7ev

Load More...

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

Want to learn more about myeloma treatment in the UK?

Join experts Graham Jackson (@profghjackson) & Martin Kaiser in this exclusive session as they discuss:

- Muk Nine b: OPTIMUM
- Myeloma XI
- Genomics in myeloma

& more!

👉http://ow.ly/qqgH50JEOpX👈

#MMsm #HemOnc

📣 Our latest podcast is now live! Join UK experts Graham Jackson & Martin Kaiser as they discuss myeloma treatment in the UK, highlighting updates from Muk Nine b: OPTIMUM, the importance of chromosome 1q & more!

🎧: http://ow.ly/Rmji50JGF6U

#MMsm #HemOnc #Myeloma

On June 24, the @US_FDA approved lisocabtagene maraleucel (liso-cel) for second-line treatment of adult patients with LBCL. The efficacy of liso-cel has been evaluated in the TRANSFORM study.

Find out more here:

👉http://ow.ly/QqNu50JJj3z👈

#LymSM #HemOnc #CARTcell #ImmunoOnc

Dr. Caspian Oliai, who recently presented positive results on Orca-T at #EHA2022, spoke with @VJHemOnc about the potential for our lead investigational high-precision cell therapy to transform treatment for #bloodcancer patients. Watch his interview here: https://bit.ly/3njs7ev

Load More...

post-ASH 2021 iwAL Virtual Workshop - apply for registration

Register for the post-ASH 2021 iwMPNs Virtual Workshop

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter